Boric acid solution alcoholic

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT BORIC ACID ALCOHOLIC SOLUTION

Composition:

Active substance: boric acid;

1 ml of solution contains 20 mg of boric acid;

Excipient: ethanol 70%.

Pharmaceutical form. 2% alcoholic solution for external use.

Main physicochemical properties: clear, colorless liquid with an alcoholic odor.

Pharmacotherapeutic group.
Antiseptics and disinfectants. ATC code D08AD.

Pharmacological properties.

The drug exerts an antiseptic effect. It coagulates proteins (including enzymes) of microbial cells, disrupts the permeability of the cell membrane, thereby inhibiting the growth and development of bacteria.

When applied externally, the drug is absorbed through damaged skin and wound surfaces; if accidentally ingested, it is absorbed through the mucous membrane of the gastrointestinal tract. Boric acid can accumulate in body tissues. It is slowly eliminated from the body.

Clinical characteristics.

Indications.

Pyoderma, weeping eczema, intertrigo, acute and chronic otitis media.

Contraindications.

Hypersensitivity to boric acid, impaired renal function, chronic mesotympanitis with normal or minimally altered mucosa, traumatic perforations of the tympanic membrane, pediatric age.

Special precautions.

Do not apply the drug to large areas of skin; do not use for cavity irrigation. Avoid contact with eyes.

In case of individual intolerance to boric acid or any component of the drug, discontinue use.

Interaction with other medicinal products and other forms of interaction.

Interaction is unknown.

Inform your doctor if using any other medicinal products simultaneously.

Usage notes.

Use during pregnancy or breastfeeding.

The drug is contraindicated in women during pregnancy or breastfeeding, as well as for the treatment of mammary glands.

Ability to influence the speed of reaction when driving vehicles or operating other machinery.

Does not affect.

Method of Administration and Dosage

For external use only. In cases of pyoderma, intertrigo, and eczema, apply the medication to affected skin areas using a gauze pad moistened with the preparation, 2–3 times daily.

For otitis, insert into the external auditory canal pledgets moistened with the solution or instill 3–5 drops 2–3 times daily.

Duration of treatment depends on the course of the disease and the therapeutic effect achieved.

Children

Do not use this medication in children.

Overdose

In case of accidental ingestion, perform gastric lavage via a tube, administer saline laxatives and enteral sorbents (activated charcoal) orally, as well as symptomatic therapy.

Symptoms of acute poisoning: nausea, vomiting, diarrhea, circulatory disturbances, central nervous system depression, hypothermia, shock, coma, and erythematous rash. In cases of severe poisoning, take measures to support vital functions, perform hemodialysis or peritoneal dialysis, and consider blood transfusion.

With prolonged use of the medication on large skin surface areas, symptoms of chronic intoxication may develop: tissue edema, exhaustion, stomatitis, eczema, menstrual cycle disturbances in women, anemia, seizures, and alopecia. In such cases, discontinue the medication and administer symptomatic treatment.

Side effects.

Immune system disorders.

The use of the drug may cause allergic reactions (skin redness, itching, urticaria, swelling). In isolated cases — development of anaphylactic reaction (up to shock).

Gastrointestinal disorders.

In some patients, especially with prolonged use, nausea, vomiting, and diarrhea may occur.

Local reactions at the site of administration: skin rashes, desquamation of the epithelium.

Nervous system disorders: headache, confusion, seizures.

Renal and urinary disorders: oliguria.

The patient should consult a physician if symptoms of the disease do not disappear during the use of the medicinal product or if adverse reactions not listed in the instructions for medical use of the medicinal product occur.

Shelf life.

3 years.

The drug must not be used after the expiry date stated on the packaging.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of the reach of children.

Packaging. 10 ml, 25 ml in bottles or 25 ml in a bottle, 1 bottle in a cardboard pack.

Prescription status. Over-the-counter.

Manufacturer.

PJSC "PHYTOPHARM".

Manufacturer's address and place of business.

Ukraine, 84500, Donetsk region, city of Bakhmut, Sybitska Street, 2.

Marketing authorization holder.

PJSC "PHYTOPHARM".

Address of the marketing authorization holder.

Ukraine, 02092, Kyiv, Almatinska Street, 12.